Atlanta, GA, July 02, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) Gareth N. Genner, Chief Executive Officer of the Company commented, “Prior to this we had a total of twenty seven issued or allowed patents and seven patents pending, covering a range of proprietary technologies encompassing AI, Biometrics and cryptography. On June 15, 2026 we filed U.S. Provisional Patent Application No. 64/091,057 entitled: “Medical Diagnostic Assurance System” (“MDAS”) for an LLM-based technology designed to avoid critical issues in medical diagnosis including confirmation bias amplification, and hallucinations that could cite invented data sources.
"Sycophantic behavior can undermine the reliability of LLM outputs in any use case, but in medical diagnosis, the consequences can be catastrophic. MDAS is intended to operate as a self-contained sovereign system with tokenization of patient identities, thereby protecting patient records from third-party access, for use only by qualified medical practitioners. MDAS does not provide a primary diagnosis but, using a three-model consensus, challenges and/or reinforces the medical practitioner’s diagnosis using data flows that ensure that the model’s research is conducted blind to that original diagnosis.
We are currently negotiating a pilot program for MDAS and aim to have the technology live in Q1 of 2027.”
Inquiries:
Trust Stamp Email: [email protected]
About Trust Stamp
Trust Stamp is a global provider of AI-powered services for use in multiple sectors including banking and finance, regulatory compliance, government, healthcare, real estate, communications, and humanitarian services. Its technology empowers organizations via advanced solutions that reduce fraud, tokenize and secure data, securely authenticate users while protecting personal privacy, reduce friction in digital transactions, and increase operational efficiency, enabling customers to accelerate secure financial inclusion and reach and serve a broader base of users worldwide.
With team members from twenty-two nationalities in eight countries across North America, Europe, Asia, and Africa, Trust Stamp trades on the Nasdaq Capital Market (Nasdaq: IDAI).
Safe Harbor Statement: Caution Concerning Forward-Looking Remarks
All statements in this release that are not based on historical fact are “forward-looking statements” including within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The information in this announcement may contain forward-looking statements and information related to, among other things, the company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events-based information currently available and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.